Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-19

Clinical Trial Update: Clinical Relevance of Typing HLA-DR7-DQ2

View source ↗

Summary

A completed clinical trial evaluated the clinical relevance of HLA-DR7-DQ2 haplotypes in patients with Celiac disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Corporacion Parc Tauli | Conditions: Celiac Disease Patients Following Recommendations of ESPGHAN, HLA-DQ2 Typing Include HLA-DR7-DQ2 Haplotypes | Status: COMPLETED